Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

L1, β-catenin, and E-cadherin expression in patients with colorectal cancer: correlation with clinicopathologic features and its prognostic significance.

Fang QX, Lü LZ, Yang B, Zhao ZS, Wu Y, Zheng XC.

J Surg Oncol. 2010 Oct 1;102(5):433-42. doi: 10.1002/jso.21537.

PMID:
20672319
2.
3.

The emergence of 'omics for the management of colorectal cancer.

Midgley RS, Church D, Kerr DJ.

Curr Opin Oncol. 2011 Jul;23(4):410-4. doi: 10.1097/CCO.0b013e328347ae49. Review.

PMID:
21577111
4.

Clinical biomarkers in colorectal cancer.

Morris V, Kopetz S.

Clin Adv Hematol Oncol. 2013 Dec;11(12):768-76. Review.

PMID:
24893280
5.

Involvement of μ-protocadherin in colorectal carcinogenesis: a promise for clinico-pathological evaluation.

Losi L, Grande A.

Histol Histopathol. 2014 Jan;29(1):11-9. doi: 10.14670/HH-29.11. Epub 2013 Aug 1. Review.

PMID:
23904255

Supplemental Content

Support Center